Jade Biosciences, Inc. · NASDAQ:JBIO
Atlas Venture Fund XII, L.P. reported a 0.20% stake in Jade Biosciences, Inc. (Schedule 13D/A)
Event Apr 28, 2025 · Filed Apr 30, 2025
Atlas Venture Fund XII, L.P. reported a 0.20% stake in Jade Biosciences, Inc., 50,992 shares, with active intent on Apr 28, 2025. Filed Apr 30, 2025 (Schedule 13D/A).
- Stake
- 0.20%
- Shares
- 50,992
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Atlas Venture Fund XII, L.P. | 0.20% | 50,992 |
| Atlas Venture Associates XII, L.P. | 0.20% | 51,406 |
| Atlas Venture Associates XII, LLC | 0.20% | 51,406 |
Source
Related
- Jade Biosciences, Inc.
- Atlas Venture Fund XII, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026